Guanacastepene A
|
WikiDoc Resources for Guanacastepene A |
|
Articles |
|---|
|
Most recent articles on Guanacastepene A Most cited articles on Guanacastepene A |
|
Media |
|
Powerpoint slides on Guanacastepene A |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Guanacastepene A at Clinical Trials.gov Trial results on Guanacastepene A Clinical Trials on Guanacastepene A at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Guanacastepene A NICE Guidance on Guanacastepene A
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Guanacastepene A Discussion groups on Guanacastepene A Patient Handouts on Guanacastepene A Directions to Hospitals Treating Guanacastepene A Risk calculators and risk factors for Guanacastepene A
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Guanacastepene A |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Guanacastepene A, or ((1R,2R,6S,8aR,10aR,E)-5-formyl-6-hydroxy-1-isopropyl-8a,10a-dimethyl-3-oxo-1,2,3,6,7,8,8a,9,10,10a-decahydrobenzo[f]azulen-2-yl acetate), is a compound showing promising antibiotic activity. It was extracted with hexane from a Costa Rican fungus (CR115), found on the branches of the Daphnopsis Americana tree and purified by chromatography.